Medical Communications, Pharma · medium ·
Shift Towards 'AI-Native Content Factory' Acquisitions in Regulated Pharma Communications, into 2027
M&A activity in medical communications will increasingly target 'AI-native content factories' and modular content platforms, specifically those offering Generative AI 'content OS' capabilities. This shift is driven by the need for compliant, cloud-based solutions to transform pharmaceutical commercialisation models and ensure content is 'AI-ready' for engagement with healthcare professionals via AI intermediaries.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.